Einstein International Journal Organization(EIJO)

Tumor markers are substances that are produced either by the tumor itself or by the body in response to the presence of cancer or certain benign conditions that can aid in the diagnosis of cancer.

These markers mostly are the proteins that are produced at a greater rate by the cancer cells. Increased levels of these substances can be detected in urine, blood, or body tissues of the patients with certain types of cancer.

These markers may be employed to predict primary or secondary tumor risk. Sometimes, non-cancerous conditions can also cause elevation of some tumor markers to be higher than normal.

Essential understanding and knowledge about the development of oral cancer, transformation of precancerous lesion to malignant lesion is very essential for making early diagnosis leading to success and prognosis of the treatment.

Complete awareness of Tumor marker can aid in earlier detection of oral cancer. In combination with other diagnostic modalities, tumor marker can support in staging, assess tumor volume and to ascertain tumour metastasis.

For these reasons, the knowledge regarding these biomarkers has increased tremendously. This article classifies the different types of tumor markers and implicates their role in some diseases.

1. Homann N, Tillonen J, Meurman JH, Rintamaaki H, Lindqvist C, et al. (2000) Increased salivary acetaldehyde levels in heavy drinkers and smokers: A microbiological approach to oral cavity cancer. Carcinogenesis 21: 663-668.
2. Liao CT, Chang JT, Wang HM, Ng SH, Hsueh C, et al. (2008) Analysis of risk factors of predictive local tumor control in oral cavity cancer. Ann Surg Oncol 15: 915-922.
3. Pindborg JJ, Mehta FS, Gupta PC, Daftary DK. Prevalence of oral submucous fibrosis among 50,915 Indian villagers. Br J Cancer 1968;22(4):646-54.
4. Schepman KP, van der Meij EH, Smeele LE, van der Waal I. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands. Oral Oncol 1998;34(4):270-5.
5. Silverman S (1998) Early diagnosis of oral cancer. Cancer 62: 1796- 1799.
6. Remmerbach TW, Weidenbach H, Pomjanski N, Knops K, Mathes S, et al. (2001) Cytologic and DNA?cytometric early diagnosis of oral cancer. Anal Cell Pathol 22: 211-221.
7. Ludwig JA, Weinstein JN (2005) Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer 5: 845-856.
8. Sharma S. Tumor markers in clinical practice: General principles and guidelines. Indian J Med Paediatr Oncol 2009;30(1):1-8.
9. 6. Lehto VP, Ponten J. Tumor markers in human biopsy material. Acta Oncol 1989;28(5):743-62.
10. Barak V, Goike H, Panaretakis KW, Einar son R. Clinical utility of Cytokeratins as tumor markers. Clin Biochem 2004;37(7):529-40.